MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2006 |
Industry |
Drug manufacturers |
Stock Exchange |
NYSESPB |
Shares |
53.5 M |
Market Cap[1] |
$ 316 M |
EBITDA (LTM) |
$ 196 M |
P/E (LTM) |
6.336735 |
P/S (LTM) |
0.447214 |
EPS (LTM) |
0.98 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Perrigo Company plc
PRGO
|
$ 15.85 | 3.28 % | $ 2.2 B | NYSE | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Harrow Health
HROW
|
$ 28.75 | 0.74 % | $ 1.06 B | Nasdaq Global Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market |  France |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
Organogenesis Holdings
ORGO
|
$ 0.87 | 3.95 % | $ 110 M | Nasdaq Capital Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 4.31 | 0.82 % | $ 170 M | Nasdaq Global Select Market,SPB | USA |
 |
Rockwell Medical
RMTI
|
$ 8.03 | -0.8 % | $ 289 M | Nasdaq Global Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Solid Biosciences
SLDB
|
$ 6.52 | 3.74 % | $ 571 M | Nasdaq Global Select Market,SPB | USA |
 |
Sundial Growers
SNDL
|
$ 1.42 | 5.19 % | $ 366 M | Nasdaq Global Select Market |  Canada |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Tilray
TLRY
|
$ 2.96 | 11.7 % | $ 331 M | Nasdaq Global Select Market | Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Veru
VERU
|
$ 2.2 | 1.85 % | $ 32.2 M | Nasdaq Capital Market | USA |
 |
China Pharma Holdings
CPHI
|
$ 0.59 | -3.35 % | $ 2.53 M | NYSE American |  China |
 |
Viatris
VTRS
|
$ 19.18 | 1.77 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |
 |
cbdMD
YCBD
|
$ 0.4 | -4.53 % | $ 1.61 M | NYSE American | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Canopy Growth Corporation
CGC
|
$ 0.75 | 6.2 % | $ 224 M | Nasdaq Global Select Market | Canada |
 |
Pacira BioSciences
PCRX
|
$ 36.42 | 0.08 % | $ 1.62 B | Nasdaq Global Select Market,SPB | USA |
 |
OrganiGram Holdings
OGI
|
$ 0.96 | 4.09 % | $ 91.5 M | Nasdaq Global Select Market | Canada |
 |
SCYNEXIS
SCYX
|
$ 3.85 | -2.41 % | $ 192 M | Nasdaq Global Select Market | USA |
 |
Aurora Cannabis
ACB
|
$ 5.23 | 1.36 % | $ 287 M | NYSE | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.47 | 3.83 % | $ 66.4 M | Nasdaq Global Select Market | USA |
 |
Cronos Group
CRON
|
$ 3.52 | 3.99 % | $ 1.35 B | Nasdaq Global Market | Canada |
 |
Evolus
EOLS
|
$ 7.5 | 1.75 % | $ 484 M | Nasdaq Global Market | USA |
 |
Bausch Health Companies
BHC
|
$ 8.35 | 2.52 % | $ 3.1 B | NYSE | Canada |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 1.11 | -2.63 % | $ 1.87 M | Nasdaq Capital Market | USA |
 |
TherapeuticsMD
TXMD
|
$ 1.82 | 2.25 % | $ 21.1 M | Nasdaq Global Select Market | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Assertio Holdings
ASRT
|
- | - | $ 150 M | Nasdaq Capital Market | USA |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.